Can Vet J 1998,39(9):559–565.PubMed 18. Vo AT, van Duijkeren E, Gaastra W, Fluit AC: Antimicrobial resistance, class 1 integrons, and genomic island
1 in Salmonella isolates from Vietnam. PLoS One 5(2):e9440. 19. Casin I, Breuil J, Brisabois A, Moury F, Grimont F, Collatz E: Multidrug-resistant human and animal Salmonella Typhimurium isolates in France belong predominantly to a DT104 clone with the chromosome- and integron-encoded beta-lactamase PSE-1. J Infect Dis 1999,179(5):1173–1182.PubMedCrossRef 20. Weill FX, Guesnier F, Guibert V, Timinouni M, Demartin M, Polomack L, Grimont PA: Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003). J Clin Microbiol 2006,44(3):700–708.PubMedCrossRef selleck products 21. Fierer J, Guiney DG: Diverse virulence traits underlying different Transmembrane Transporters inhibitor clinical outcomes of Salmonella infection. J Clin Invest 2001,107(7):775–780.PubMedCrossRef 22. Porwollik S, Boyd EF, Choy C, Cheng P, Florea L, Proctor E, McClelland M: Characterization of Salmonella enterica subspecies I genovars by use of microarrays. J Bacteriol 2004,186(17):5883–5898.PubMedCrossRef 23. Cloeckaert A, Schwarz S: Molecular characterization, spread and evolution of multidrug Liproxstatin-1 in vitro resistance in
Salmonella enterica Typhimurium DT104. Vet Res (Paris) 2001,32(3–4):301–310. 24. Doublet B, Boyd D, Mulvey MR, Cloeckaert A: The Salmonella genomic island 1 is an integrative mobilizable element. Mol Microbiol 2005,55(6):1911–1924.PubMedCrossRef 25. Miller MB, Tang YW: Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009,22(4):611–633.PubMedCrossRef 26. Scaria J, Palaniappan RU, Chiu D, Phan JA, Ponnala L, McDonough P, Grohn YT, Molecular motor Porwollik S, McClelland M, Chiou CS, Chu C, Chang YF: Microarray for molecular typing of Salmonella enterica serovars. Mol Cell Probes 2008,22(4):238–243.PubMedCrossRef Authors’ contributions The macro-array was designed by PF, MB and AB. MB performed all the laboratory analyses. The results were analyzed and interpreted by MB, PF and AB. SAG gave special attention to the antimicrobial
resistance aspect of data and the choice of control strains. FXW was responsible for the clinical isolates and performed some phage-typing assays. All the authors were involved in drafting or revising the manuscript. The authors read and approved the final manuscript.”
“Introduction Salmonella species are recognized as agents of illness and disease in both humans and animals with greater than 2000 serotypes recognized; the gastrointestinal tract of animals is considered the primary reservoir of the pathogen with human illness usually linked to exposure to contaminated animal-derived products such as meat or poultry [1, 2]. Annually in the US Salmonella is estimated to cause approximately 1 million illnesses, 19,000 hospitalizations and approximately 378 deaths .